The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical Regulatory Affairs Market Research Report 2025
Synopsis
Pharmaceutical Regulatory Affairs, or Pharma Regulatory Affairs, refers to the professionals who maintain regulations from within the industry. The pharmaceutical industry is the most regulated of all industries. Regulatory affairs professionals are key, but perhaps overlooked, players in drug development. They are the primary communications link between the company and agencies such as FDA, and they are responsible for keeping up with the increasing scope and complexity of regulations. In the pharmaceutical industry, regulatory affairs professionals have expertise in the legal and regulatory environments, as well as in clinical research protocols.
The global Pharmaceutical Regulatory Affairs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Regulatory Affairs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Regulatory Affairs.
Report Scope
The Pharmaceutical Regulatory Affairs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Regulatory Affairs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Regulatory Affairs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
QuintilesIMS
LabCor
PAREXEL
Pharmaceutical Product Development
INC RESEARCH HOLDINGS
PRA Health Sciences
ICON
Charles River
Advent International
WuXi AppTec, Inc.
Pharmaron Beijing Co., Ltd.
Hangzhou Tigermed Consulting Co.,Ltd.
Asymchem Laboratories (Tianjin) Co.,Ltd.
Accell Clinical Research, LLC.
GenPact Ltd.
Criterium, Inc.
Promedica International
Medpace
Covance
Freyr
Segment by Type
Regulatory Consulting
Legal Representation
Regulatory Writing & Publishing
Product Registration & Clinical Trial Application
Other Services
Segment by Application
In-house
Outsourcing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Regulatory Affairs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Pharmaceutical Regulatory Affairs, or Pharma Regulatory Affairs, refers to the professionals who maintain regulations from within the industry. The pharmaceutical industry is the most regulated of all industries. Regulatory affairs professionals are key, but perhaps overlooked, players in drug development. They are the primary communications link between the company and agencies such as FDA, and they are responsible for keeping up with the increasing scope and complexity of regulations. In the pharmaceutical industry, regulatory affairs professionals have expertise in the legal and regulatory environments, as well as in clinical research protocols.
The global Pharmaceutical Regulatory Affairs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Regulatory Affairs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Regulatory Affairs.
Report Scope
The Pharmaceutical Regulatory Affairs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Regulatory Affairs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Regulatory Affairs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
QuintilesIMS
LabCor
PAREXEL
Pharmaceutical Product Development
INC RESEARCH HOLDINGS
PRA Health Sciences
ICON
Charles River
Advent International
WuXi AppTec, Inc.
Pharmaron Beijing Co., Ltd.
Hangzhou Tigermed Consulting Co.,Ltd.
Asymchem Laboratories (Tianjin) Co.,Ltd.
Accell Clinical Research, LLC.
GenPact Ltd.
Criterium, Inc.
Promedica International
Medpace
Covance
Freyr
Segment by Type
Regulatory Consulting
Legal Representation
Regulatory Writing & Publishing
Product Registration & Clinical Trial Application
Other Services
Segment by Application
In-house
Outsourcing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Regulatory Affairs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Regulatory Affairs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Regulatory Consulting
1.2.3 Legal Representation
1.2.4 Regulatory Writing & Publishing
1.2.5 Product Registration & Clinical Trial Application
1.2.6 Other Services
1.3 Market by Application
1.3.1 Global Pharmaceutical Regulatory Affairs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 In-house
1.3.3 Outsourcing
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Regulatory Affairs Market Perspective (2019-2030)
2.2 Pharmaceutical Regulatory Affairs Growth Trends by Region
2.2.1 Global Pharmaceutical Regulatory Affairs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical Regulatory Affairs Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical Regulatory Affairs Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical Regulatory Affairs Market Dynamics
2.3.1 Pharmaceutical Regulatory Affairs Industry Trends
2.3.2 Pharmaceutical Regulatory Affairs Market Drivers
2.3.3 Pharmaceutical Regulatory Affairs Market Challenges
2.3.4 Pharmaceutical Regulatory Affairs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Regulatory Affairs Players by Revenue
3.1.1 Global Top Pharmaceutical Regulatory Affairs Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical Regulatory Affairs Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Regulatory Affairs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Regulatory Affairs Revenue
3.4 Global Pharmaceutical Regulatory Affairs Market Concentration Ratio
3.4.1 Global Pharmaceutical Regulatory Affairs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Regulatory Affairs Revenue in 2023
3.5 Pharmaceutical Regulatory Affairs Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Regulatory Affairs Product Solution and Service
3.7 Date of Enter into Pharmaceutical Regulatory Affairs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Regulatory Affairs Breakdown Data by Type
4.1 Global Pharmaceutical Regulatory Affairs Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical Regulatory Affairs Breakdown Data by Application
5.1 Global Pharmaceutical Regulatory Affairs Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Regulatory Affairs Market Size (2019-2030)
6.2 North America Pharmaceutical Regulatory Affairs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical Regulatory Affairs Market Size by Country (2019-2024)
6.4 North America Pharmaceutical Regulatory Affairs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Regulatory Affairs Market Size (2019-2030)
7.2 Europe Pharmaceutical Regulatory Affairs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical Regulatory Affairs Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical Regulatory Affairs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical Regulatory Affairs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Regulatory Affairs Market Size (2019-2030)
9.2 Latin America Pharmaceutical Regulatory Affairs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical Regulatory Affairs Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical Regulatory Affairs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical Regulatory Affairs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 QuintilesIMS
11.1.1 QuintilesIMS Company Detail
11.1.2 QuintilesIMS Business Overview
11.1.3 QuintilesIMS Pharmaceutical Regulatory Affairs Introduction
11.1.4 QuintilesIMS Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.1.5 QuintilesIMS Recent Development
11.2 LabCor
11.2.1 LabCor Company Detail
11.2.2 LabCor Business Overview
11.2.3 LabCor Pharmaceutical Regulatory Affairs Introduction
11.2.4 LabCor Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.2.5 LabCor Recent Development
11.3 PAREXEL
11.3.1 PAREXEL Company Detail
11.3.2 PAREXEL Business Overview
11.3.3 PAREXEL Pharmaceutical Regulatory Affairs Introduction
11.3.4 PAREXEL Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.3.5 PAREXEL Recent Development
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Detail
11.4.2 Pharmaceutical Product Development Business Overview
11.4.3 Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Introduction
11.4.4 Pharmaceutical Product Development Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.4.5 Pharmaceutical Product Development Recent Development
11.5 INC RESEARCH HOLDINGS
11.5.1 INC RESEARCH HOLDINGS Company Detail
11.5.2 INC RESEARCH HOLDINGS Business Overview
11.5.3 INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Introduction
11.5.4 INC RESEARCH HOLDINGS Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.5.5 INC RESEARCH HOLDINGS Recent Development
11.6 PRA Health Sciences
11.6.1 PRA Health Sciences Company Detail
11.6.2 PRA Health Sciences Business Overview
11.6.3 PRA Health Sciences Pharmaceutical Regulatory Affairs Introduction
11.6.4 PRA Health Sciences Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.6.5 PRA Health Sciences Recent Development
11.7 ICON
11.7.1 ICON Company Detail
11.7.2 ICON Business Overview
11.7.3 ICON Pharmaceutical Regulatory Affairs Introduction
11.7.4 ICON Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.7.5 ICON Recent Development
11.8 Charles River
11.8.1 Charles River Company Detail
11.8.2 Charles River Business Overview
11.8.3 Charles River Pharmaceutical Regulatory Affairs Introduction
11.8.4 Charles River Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.8.5 Charles River Recent Development
11.9 Advent International
11.9.1 Advent International Company Detail
11.9.2 Advent International Business Overview
11.9.3 Advent International Pharmaceutical Regulatory Affairs Introduction
11.9.4 Advent International Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.9.5 Advent International Recent Development
11.10 WuXi AppTec, Inc.
11.10.1 WuXi AppTec, Inc. Company Detail
11.10.2 WuXi AppTec, Inc. Business Overview
11.10.3 WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Introduction
11.10.4 WuXi AppTec, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.10.5 WuXi AppTec, Inc. Recent Development
11.11 Pharmaron Beijing Co., Ltd.
11.11.1 Pharmaron Beijing Co., Ltd. Company Detail
11.11.2 Pharmaron Beijing Co., Ltd. Business Overview
11.11.3 Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Introduction
11.11.4 Pharmaron Beijing Co., Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.11.5 Pharmaron Beijing Co., Ltd. Recent Development
11.12 Hangzhou Tigermed Consulting Co.,Ltd.
11.12.1 Hangzhou Tigermed Consulting Co.,Ltd. Company Detail
11.12.2 Hangzhou Tigermed Consulting Co.,Ltd. Business Overview
11.12.3 Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Introduction
11.12.4 Hangzhou Tigermed Consulting Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.12.5 Hangzhou Tigermed Consulting Co.,Ltd. Recent Development
11.13 Asymchem Laboratories (Tianjin) Co.,Ltd.
11.13.1 Asymchem Laboratories (Tianjin) Co.,Ltd. Company Detail
11.13.2 Asymchem Laboratories (Tianjin) Co.,Ltd. Business Overview
11.13.3 Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Introduction
11.13.4 Asymchem Laboratories (Tianjin) Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.13.5 Asymchem Laboratories (Tianjin) Co.,Ltd. Recent Development
11.14 Accell Clinical Research, LLC.
11.14.1 Accell Clinical Research, LLC. Company Detail
11.14.2 Accell Clinical Research, LLC. Business Overview
11.14.3 Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Introduction
11.14.4 Accell Clinical Research, LLC. Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.14.5 Accell Clinical Research, LLC. Recent Development
11.15 GenPact Ltd.
11.15.1 GenPact Ltd. Company Detail
11.15.2 GenPact Ltd. Business Overview
11.15.3 GenPact Ltd. Pharmaceutical Regulatory Affairs Introduction
11.15.4 GenPact Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.15.5 GenPact Ltd. Recent Development
11.16 Criterium, Inc.
11.16.1 Criterium, Inc. Company Detail
11.16.2 Criterium, Inc. Business Overview
11.16.3 Criterium, Inc. Pharmaceutical Regulatory Affairs Introduction
11.16.4 Criterium, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.16.5 Criterium, Inc. Recent Development
11.17 Promedica International
11.17.1 Promedica International Company Detail
11.17.2 Promedica International Business Overview
11.17.3 Promedica International Pharmaceutical Regulatory Affairs Introduction
11.17.4 Promedica International Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.17.5 Promedica International Recent Development
11.18 Medpace
11.18.1 Medpace Company Detail
11.18.2 Medpace Business Overview
11.18.3 Medpace Pharmaceutical Regulatory Affairs Introduction
11.18.4 Medpace Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.18.5 Medpace Recent Development
11.19 Covance
11.19.1 Covance Company Detail
11.19.2 Covance Business Overview
11.19.3 Covance Pharmaceutical Regulatory Affairs Introduction
11.19.4 Covance Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.19.5 Covance Recent Development
11.20 Freyr
11.20.1 Freyr Company Detail
11.20.2 Freyr Business Overview
11.20.3 Freyr Pharmaceutical Regulatory Affairs Introduction
11.20.4 Freyr Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024)
11.20.5 Freyr Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pharmaceutical Regulatory Affairs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Regulatory Consulting
Table 3. Key Players of Legal Representation
Table 4. Key Players of Regulatory Writing & Publishing
Table 5. Key Players of Product Registration & Clinical Trial Application
Table 6. Key Players of Other Services
Table 7. Global Pharmaceutical Regulatory Affairs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Pharmaceutical Regulatory Affairs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Pharmaceutical Regulatory Affairs Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Pharmaceutical Regulatory Affairs Market Share by Region (2019-2024)
Table 11. Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Pharmaceutical Regulatory Affairs Market Share by Region (2025-2030)
Table 13. Pharmaceutical Regulatory Affairs Market Trends
Table 14. Pharmaceutical Regulatory Affairs Market Drivers
Table 15. Pharmaceutical Regulatory Affairs Market Challenges
Table 16. Pharmaceutical Regulatory Affairs Market Restraints
Table 17. Global Pharmaceutical Regulatory Affairs Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Pharmaceutical Regulatory Affairs Market Share by Players (2019-2024)
Table 19. Global Top Pharmaceutical Regulatory Affairs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Regulatory Affairs as of 2023)
Table 20. Ranking of Global Top Pharmaceutical Regulatory Affairs Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Pharmaceutical Regulatory Affairs Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pharmaceutical Regulatory Affairs Product Solution and Service
Table 24. Date of Enter into Pharmaceutical Regulatory Affairs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pharmaceutical Regulatory Affairs Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Type (2019-2024)
Table 28. Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Type (2025-2030)
Table 30. Global Pharmaceutical Regulatory Affairs Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Application (2019-2024)
Table 32. Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Application (2025-2030)
Table 34. North America Pharmaceutical Regulatory Affairs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Pharmaceutical Regulatory Affairs Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Pharmaceutical Regulatory Affairs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Pharmaceutical Regulatory Affairs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Pharmaceutical Regulatory Affairs Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Pharmaceutical Regulatory Affairs Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Pharmaceutical Regulatory Affairs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Pharmaceutical Regulatory Affairs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Pharmaceutical Regulatory Affairs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country (2025-2030) & (US$ Million)
Table 49. QuintilesIMS Company Detail
Table 50. QuintilesIMS Business Overview
Table 51. QuintilesIMS Pharmaceutical Regulatory Affairs Product
Table 52. QuintilesIMS Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 53. QuintilesIMS Recent Development
Table 54. LabCor Company Detail
Table 55. LabCor Business Overview
Table 56. LabCor Pharmaceutical Regulatory Affairs Product
Table 57. LabCor Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 58. LabCor Recent Development
Table 59. PAREXEL Company Detail
Table 60. PAREXEL Business Overview
Table 61. PAREXEL Pharmaceutical Regulatory Affairs Product
Table 62. PAREXEL Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 63. PAREXEL Recent Development
Table 64. Pharmaceutical Product Development Company Detail
Table 65. Pharmaceutical Product Development Business Overview
Table 66. Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Product
Table 67. Pharmaceutical Product Development Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 68. Pharmaceutical Product Development Recent Development
Table 69. INC RESEARCH HOLDINGS Company Detail
Table 70. INC RESEARCH HOLDINGS Business Overview
Table 71. INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Product
Table 72. INC RESEARCH HOLDINGS Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 73. INC RESEARCH HOLDINGS Recent Development
Table 74. PRA Health Sciences Company Detail
Table 75. PRA Health Sciences Business Overview
Table 76. PRA Health Sciences Pharmaceutical Regulatory Affairs Product
Table 77. PRA Health Sciences Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 78. PRA Health Sciences Recent Development
Table 79. ICON Company Detail
Table 80. ICON Business Overview
Table 81. ICON Pharmaceutical Regulatory Affairs Product
Table 82. ICON Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 83. ICON Recent Development
Table 84. Charles River Company Detail
Table 85. Charles River Business Overview
Table 86. Charles River Pharmaceutical Regulatory Affairs Product
Table 87. Charles River Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 88. Charles River Recent Development
Table 89. Advent International Company Detail
Table 90. Advent International Business Overview
Table 91. Advent International Pharmaceutical Regulatory Affairs Product
Table 92. Advent International Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 93. Advent International Recent Development
Table 94. WuXi AppTec, Inc. Company Detail
Table 95. WuXi AppTec, Inc. Business Overview
Table 96. WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Product
Table 97. WuXi AppTec, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 98. WuXi AppTec, Inc. Recent Development
Table 99. Pharmaron Beijing Co., Ltd. Company Detail
Table 100. Pharmaron Beijing Co., Ltd. Business Overview
Table 101. Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Product
Table 102. Pharmaron Beijing Co., Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 103. Pharmaron Beijing Co., Ltd. Recent Development
Table 104. Hangzhou Tigermed Consulting Co.,Ltd. Company Detail
Table 105. Hangzhou Tigermed Consulting Co.,Ltd. Business Overview
Table 106. Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Product
Table 107. Hangzhou Tigermed Consulting Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 108. Hangzhou Tigermed Consulting Co.,Ltd. Recent Development
Table 109. Asymchem Laboratories (Tianjin) Co.,Ltd. Company Detail
Table 110. Asymchem Laboratories (Tianjin) Co.,Ltd. Business Overview
Table 111. Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Product
Table 112. Asymchem Laboratories (Tianjin) Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 113. Asymchem Laboratories (Tianjin) Co.,Ltd. Recent Development
Table 114. Accell Clinical Research, LLC. Company Detail
Table 115. Accell Clinical Research, LLC. Business Overview
Table 116. Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Product
Table 117. Accell Clinical Research, LLC. Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 118. Accell Clinical Research, LLC. Recent Development
Table 119. GenPact Ltd. Company Detail
Table 120. GenPact Ltd. Business Overview
Table 121. GenPact Ltd. Pharmaceutical Regulatory Affairs Product
Table 122. GenPact Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 123. GenPact Ltd. Recent Development
Table 124. Criterium, Inc. Company Detail
Table 125. Criterium, Inc. Business Overview
Table 126. Criterium, Inc. Pharmaceutical Regulatory Affairs Product
Table 127. Criterium, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 128. Criterium, Inc. Recent Development
Table 129. Promedica International Company Detail
Table 130. Promedica International Business Overview
Table 131. Promedica International Pharmaceutical Regulatory Affairs Product
Table 132. Promedica International Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 133. Promedica International Recent Development
Table 134. Medpace Company Detail
Table 135. Medpace Business Overview
Table 136. Medpace Pharmaceutical Regulatory Affairs Product
Table 137. Medpace Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 138. Medpace Recent Development
Table 139. Covance Company Detail
Table 140. Covance Business Overview
Table 141. Covance Pharmaceutical Regulatory Affairs Product
Table 142. Covance Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 143. Covance Recent Development
Table 144. Freyr Company Detail
Table 145. Freyr Business Overview
Table 146. Freyr Pharmaceutical Regulatory Affairs Product
Table 147. Freyr Revenue in Pharmaceutical Regulatory Affairs Business (2019-2024) & (US$ Million)
Table 148. Freyr Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Regulatory Affairs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pharmaceutical Regulatory Affairs Market Share by Type: 2023 VS 2030
Figure 3. Regulatory Consulting Features
Figure 4. Legal Representation Features
Figure 5. Regulatory Writing & Publishing Features
Figure 6. Product Registration & Clinical Trial Application Features
Figure 7. Other Services Features
Figure 8. Global Pharmaceutical Regulatory Affairs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Pharmaceutical Regulatory Affairs Market Share by Application: 2023 VS 2030
Figure 10. In-house Case Studies
Figure 11. Outsourcing Case Studies
Figure 12. Pharmaceutical Regulatory Affairs Report Years Considered
Figure 13. Global Pharmaceutical Regulatory Affairs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Pharmaceutical Regulatory Affairs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Pharmaceutical Regulatory Affairs Market Share by Region: 2023 VS 2030
Figure 16. Global Pharmaceutical Regulatory Affairs Market Share by Players in 2023
Figure 17. Global Top Pharmaceutical Regulatory Affairs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Regulatory Affairs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutical Regulatory Affairs Revenue in 2023
Figure 19. North America Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Pharmaceutical Regulatory Affairs Market Share by Country (2019-2030)
Figure 21. United States Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Pharmaceutical Regulatory Affairs Market Share by Country (2019-2030)
Figure 25. Germany Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Pharmaceutical Regulatory Affairs Market Share by Region (2019-2030)
Figure 33. China Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Pharmaceutical Regulatory Affairs Market Share by Country (2019-2030)
Figure 41. Mexico Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Pharmaceutical Regulatory Affairs Market Share by Country (2019-2030)
Figure 45. Turkey Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Pharmaceutical Regulatory Affairs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. QuintilesIMS Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 48. LabCor Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 49. PAREXEL Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 50. Pharmaceutical Product Development Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 51. INC RESEARCH HOLDINGS Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 52. PRA Health Sciences Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 53. ICON Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 54. Charles River Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 55. Advent International Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 56. WuXi AppTec, Inc. Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 57. Pharmaron Beijing Co., Ltd. Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 58. Hangzhou Tigermed Consulting Co.,Ltd. Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 59. Asymchem Laboratories (Tianjin) Co.,Ltd. Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 60. Accell Clinical Research, LLC. Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 61. GenPact Ltd. Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 62. Criterium, Inc. Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 63. Promedica International Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 64. Medpace Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 65. Covance Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 66. Freyr Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
